CD40 and pancreatic neoplasm: Engagement of CD40 permitted to overcome resistance to anti-PD1 therapy through repolarization of macrophages towards an inflammatory phenotype, leading to strong CD8 T cell activation in a intrahepatic cholangiocarcinoma [283] genetic mouse model of bladder [284] and pancreatic cancer [285].